Receive Information

Alcidion Corporation 

  • Alcidion is the brainchild of the former CEO of the SA Heath Department and Professor Malcolm Pradhan, a Stanford qualified physician. Over the past decade, Alcidion has invested $15m into the R&D of the cutting edge Clinical Decision Support System and is now focussed on commercializing the technology. 
  • The introduction of Patient Protection & Affordable Care Act 2010 (“Obamacare”) requires US hospitals to accelerate the adoption of Electronic Medical Records.  Alcidion is a leading supplier of these systems in Australia and is now seeking to expand its operations into the United States. 
  • The company is backed by Allure Capital, the private investment vehicle of technology entrepreneur Mr. Nathan Buzza and BlueSky Private Equity (ASX:BLA).  Mr Buzza was previously the second largest shareholder of Clinical Middleware Provider, Azure Healthcare (ASX:AZV), which catapulted into the spotlight after the stock rocketed from 3.3c to 34c over his two and a half year tenure.